Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

6 clinical studies listed.

Filters:

Fatigue in Multiple Sclerosis

Tundra lists 6 Fatigue in Multiple Sclerosis clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT07924410

Tele-rehabilitation Program in People With Multiple Sclerosis and Mild Disability

MS-FatigueCARE is a prospective, multicenter study aimed at investigating the mechanisms underlying fatigue in people with multiple sclerosis (MS) and mild disability, and at evaluating the efficacy of a personalized home-based telerehabilitation program. Fatigue is one of the most debilitating symptoms of MS and can significantly impact daily activities and quality of life, even in individuals with low levels of neurological disability. Current assessment relies primarily on patient-reported measures, highlighting the need for objective and sensitive fatigue biomarkers. The study comprises two complementary phases. Phase 1 is a cross-sectional observational study comparing people with relapsing-remitting MS and mild disability (EDSS score 0-3.5) with healthy controls. The objective is to investigate the relationship between perceived fatigue and objective physiological and motor parameters, focusing specifically on oxygen consumption (VO₂), the metabolic cost of walking (CW), postural control, and gait-related parameters. In participants with MS, the potential association between fatigue and Epstein-Barr virus (EBV) serological status or reactivation will also be examined. Phase 2 is a single-blind, randomized controlled crossover study involving MS participants who completed Phase 1. Participants will be randomly assigned to either a six-week multidomain telerehabilitation program-based on non-immersive virtual reality and "serious games"-or a self-managed therapeutic education program. The telerehabilitation intervention integrates motor, cognitive, and cardiorespiratory exercises to be performed at home four times a week for 60 minutes, with remote monitoring by rehabilitation professionals. After a six-week washout period, participants will switch to the alternative intervention. The primary outcome is the energy cost of walking, measured during the 6-Minute Walking Test. Secondary outcomes include subjective fatigue, cognitive and psychological functioning, walking and balance performance, quality of life, usability, and treatment adherence, as well as instrumental measures of VO₂/VCO₂, postural control, and lower-limb kinematics. Overall, MS-FatigueCARE aims to identify objective markers of fatigue and determine whether a personalized, multi-domain telerehabilitation approach can reduce fatigue and improve functional outcomes and quality of life for people with MS, while fostering accessible and continuous rehabilitative care.

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-11-09

1 state

Multiple Sclerosis
Fatigue in Multiple Sclerosis
RECRUITING

NCT07504120

The Effect of Remotely Delivered Pilates on Physical , and Psychological Outcomes in Individuals With Multiple Sclerosis

Objectives Objective 1: To determine the effects of a 16-week remotely delivered Pilates intervention on walking endurance, walking speed, balance, fatigue, and pain compared to a waitlist control group in individuals with MS. Objective 2: To examine the impact of a 16-week remotely delivered Pilates intervention on depression \& anxiety, cognitive function, and QOL compared to a waitlist control group in individuals with MS. Aim Aim 1: To assess whether the 16-week remotely delivered Pilates intervention significantly improves walking endurance, walking speed, balance, fatigue, and pain compared to a waitlist control group in individuals with MS Aim 2: To investigate whether the 16-week remotely delivered Pilates intervention significantly improves depression \& anxiety, cognitive function, and QOL compared to a waitlist control group in individuals with MS. Hypothesis Hypothesis 1: The 16-week remotely delivered Pilates intervention will significantly improve walking endurance, walking speed, balance, fatigue, and pain compared to a waitlist control group in individuals with MS. Hypothesis 2: Participants receiving the 16-week remotely delivered Pilates intervention will demonstrate significantly greater improvements in depression \& anxiety, cognitive function, and QOL compared to a waitlist control group in individuals with MS.

Gender: All

Ages: 18 Years - Any

Updated: 2026-10-06

1 state

Multiple Sclerosis
Pilates Exercise
Walking
+7
COMPLETED

NCT07680738

Transcranial Direct Current Stimulation for Fatigue, Mood, and Cognition in Multiple Sclerosis

Multiple sclerosis (MS) is a chronic, inflammatory and disabling disease of the Cnetral Nervous System characterized by relapsing and / or progressive somatosensory, motor and vestibular clinical manifestations. Moreover, fatigue, depression, anxiety, and cognitive impairment are also present in most MS patients. These symptoms substantially impact quality of life and often show limited response to conventional pharmacological treatment. Transcranial direct current stimulation (tDCS) is a non-invasive technique that applies a weak direct current to the scalp via surface electrodes, modulating cortical excitability in a polarity-dependent manner. The objective of this study is to evaluate the efficacy and safety of tDCS for fatigue, depression, anxiety, and cognitive performance in patients with relapsing or progressive MS.

Gender: All

Ages: 18 Years - 55 Years

Updated: 2026-07-02

Multiple Sclerosis, MS
Multiple Sclerosis
Multiple Sclerosis (MS) - Relapsing-remitting
+5
RECRUITING

NCT07438964

Non-invasive Brain Stimulation in Multiple Sclerosis Fatigue

The neurobiological basis of central fatigue in multiple sclerosis remained unclear so far. This study investigates reward-related brain mechanisms, inflammation, and their modulation by non-invasive brain stimulation using fMRI, proteomics, and clinical measures to improve future treatment of central fatigue in MS. In the study, persons suffering from relapsing-remitting MS (RRMS) with vs. without comorbid central fatigue will be included. The study comprises five experimental visits conducted at Charité University Medicine on five consecutive days (i.e., V1 - V5) and two follow-up visits two (V6) and four (V7) weeks after V5. True or sham anodal transcranial Direct Current Stimulation (tDCS) is applied to the left dorsolateral prefrontal cortex (dlPFC) at the five visits V1 to V5. All primary and secondary outcomes are assessed at V1 and V5. At V6 and V7, measures of central fatigue are additionally assessed via questionnaires which are send to and back from the patients via mail. Participants of all groups will participate in all visits.

Gender: All

Ages: 18 Years - 70 Years

Updated: 2026-02-27

1 state

Multiple Sclerosis
Fatigue in Multiple Sclerosis
RECRUITING

NCT07193823

Sexual Dysfunction in Women With Multiple Sclerosis (MS)

Sexual dysfunction in women with multiple sclerosis (MS) is an important yet often overlooked problem. The primary objective of this study is to investigate the prevalence of sexual dysfunction in female patients diagnosed with MS. The secondary objective is to evaluate the relationship between sexual dysfunction and fatigue, depression, anxiety, overactive bladder symptoms, and cognitive dysfunction. For this purpose, the following validated instruments will be used: the Female Sexual Function Index (FSFI) to assess sexual dysfunction, the Brief International Cognitive Assessment for MS (BICAMS) to evaluate cognitive function, the Hospital Anxiety and Depression Scale (HADS) to assess depression and anxiety, the Fatigue Severity Scale (FSS) to measure fatigue, and the Overactive Bladder Questionnaire (OAB-V8) to evaluate overactive bladder symptoms.

Gender: FEMALE

Ages: 25 Years - 50 Years

Updated: 2025-09-26

1 state

Multiple Sclerosis
Multiple Sclerosis (MS) - Relapsing-remitting
Fatigue in Multiple Sclerosis
+6
ENROLLING BY INVITATION

NCT07025122

Fatigue in Multiple Sclerosis and Its Relationship to Inflammatory and Neurodegenerative Markers of the Disease

The study is focused on several independent quantifiable biomarkers (sNfL, sGFAP, mitochondrial activity, genetics and fatigue tests) to obtain more detailed information about MS and its progression. Based on the results, investigator will further attempt to predict the course of the disease and manage the therapy more effectively to prevent worsening of the patient's condition.

Gender: All

Ages: 18 Years - Any

Updated: 2025-06-17

1 state

Fatigue in Multiple Sclerosis
Multiple Sclerosis
Neurofilaments Light Chains
+4